Navigation Links
InCube Labs Enters into an Agreement with the Engineering Research Center for Revolutionizing Metallic Biomaterials
Date:10/23/2013

SAN JOSE, Calif., Oct. 23, 2013 /PRNewswire/ -- InCube Labs, a life sciences research lab focused on developing and commercializing medical breakthroughs, today announced it has entered into an agreement with the Engineering Research Center for Revolutionizing Metallic Biomaterials (ERC-RMB). 

The ERC-RMB is funded by the National Science Foundation and led by North Carolina Agricultural and Technical State University in Greensboro (N.C. A&T) in collaboration with the University of Pittsburgh (Pitt), the University of Cincinnati, and Hannover Medical School in Germany. Its mission is to develop and commercialize novel bioresorbable metal alloys that have potential applications in implantable medical devices.  As part of this collaboration, InCube Labs has entered into an agreement to evaluate potential clinical utility of the novel biomaterials being developed at the ERC-RMB.

"The mission of the ERC-RMB is to create next-generation, revolutionary biological metallic interface materials for engineered systems implanted in the human body. Our team of innovative engineers has made strong progress in advancing our bioresorbable metals technologies, and we have been testing their use in clinically relevant device prototypes," said Dr. Jag Sankar, ERC Director and Distinguished Professor of Mechanical Engineering at N.C. A&T. 

Sankar continued, "Our next step now is to work with industry to bring these innovations to market and to patients. InCube Labs has a tremendous track record of success in developing and commercializing breakthrough technologies, and we are thrilled with this relationship with InCube to advance our novel biomaterials to the next phase of development." 

"The University of Pittsburgh is deeply committed to bridging the gap between academia and industry to promote and commercialize new technologies," said Dr. Harvey Borovetz, Distinguished Professor and Former Chair, Department of Bioengineering at Pitt. "Our relationship and agreement with InCube will help us harness scientific discoveries and translate them into commercial products that will ultimately improve healthcare."

"Through our strategic relationship with Pitt and its Coulter Translational Research Partnership program, we became engaged with the ERC-RMB. We have been very impressed with the team, the facilities and capabilities that Dr. Sankar has assembled, and we look forward to a long term relationship that accelerates the pace of innovation, and delivers more effective solutions to patients," said Mir Imran, Chairman and CEO, InCube Labs. "We are particularly excited about evaluating the biomaterials that the ERC-RMB is pioneering for commercial applications. We believe these innovations could lead to important clinical solutions that would dramatically improve patient outcomes."

As part of InCube Labs' efforts to commercialize innovative technologies, the company has a number of relationships with premier Universities around the country. These collaborations range from evaluating intellectual property for commercial viability to training and mentoring aspiring entrepreneurs and scientists.

About InCube Labs

Based in San Jose and San Antonio, InCube Labs is a life sciences research lab focused on developing medical breakthroughs that dramatically improve patient outcomes. InCube is led by Mir Imran, an accomplished medical innovator, entrepreneur and venture capitalist, who has founded more than 20 life sciences companies and holds more than 200 patents. Many of Imran's innovations have resulted in new standards of care, including the first FDA-approved Automatic Implantable Cardioverter Defibrillator. For more information, please go to www.incubelabs.com.

About the Engineering Research Center for Revolutionizing Metallic Biomaterials             

The ERC-RMB is conducting research in biomedical engineering and nano-bio applications. It is funded by the National Science Foundation. Its goal is to generate revolutionary advances in medicine through the development of biocompatible and biodegradable materials to be used in implants for reconstruction and regeneration. North Carolina A&T is the ERC's lead institution; partners include the University of Pittsburgh, University of Cincinnati, and Hannover Medical School in Germany. NSF Engineering Research Centers are considered landmarks in federal support for university research in partnership with industry to produce innovative technologies and significantly enhance the competitiveness of the U.S. economy. For more information, please go to erc.ncat.edu.


'/>"/>
SOURCE InCube Labs
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. InCube Labs Launches Two New Life Sciences Companies in San Antonio
2. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
3. Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis
4. CyberKnife System and the da Vinci Surgical System in Concord Medical Centers Achieve Over RMB 10 Million in Medical Revenue Since Opening in February
5. 3 Pediatric Centers that Offer SynCardia Total Artificial Heart Named in Top 10 for "Best Childrens Hospitals"
6. Abaxis Enters Into Definitive Agreement To Deliver 300 Piccolo Xpress Instruments For A Four-Year Drug Clinical Trial
7. The Galien Foundation Announces Roster of Luminary Presenters for Third Galien Forum; Program Highlights Include CEO Panel, Panel on Alzheimers Disease Innovation, Nobel Laureate Elie Wiesel
8. ApolloMed ACO Selected To Participate In A Transformative New Initiative Sponsored by the Centers for Medicare and Medicaid Services
9. Spine Pain Management Opens Two Additional Affiliate Diagnostic Centers in Florida
10. Caspase Inhibitor Enters Clinical Trial In Islet Transplantation As Treatment For Diabetes
11. CVS Caremark Charitable Trust Partners with National Association of Community Health Centers to Create Innovative Grant Program Focused on Managing Chronic Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... 2017   Spotlight Innovation Inc. (OTCQB: ... in the second quarter of 2017, to launch ... to provide relief from chronic pain, is a ... was developed under a licensing agreement with Dr. ... from snake venom. Additionally, Caretta Therapeutics has signed ...
(Date:1/18/2017)... , Jan 18, 2017 Research and Markets ... Vomiting Drugs Market 2017-2021" report to their offering. ... The global CINV drugs ... 2017-2021. Global Thoracic Surgery Market 2017-2021, has been ... experts. The report covers the market landscape and its growth prospects ...
(Date:1/18/2017)... -- In China , we say Health ... of China,s Healthy Strategy originates. 2016 ... Economic and Social Development of the People,s Republic ... state council of the People,s Republic of China ... development plan, identifying medical devices as one of the main ...
Breaking Medicine Technology:
(Date:1/18/2017)... ... 2017 , ... At Hallmark Nameplate, their commitment to quality is what sets ... ISO 13485. This certification is another way they are making constant strides to provide ... they need. , The ISO 13485 Certification is a major accomplishment for Hallmark Nameplate ...
(Date:1/18/2017)... ... January 18, 2017 , ... Michael ... new website for its Center for Biosimilars, announced Michael J. Hennessy Associates, Inc. ... in the field of biosimilars through thought leader interaction in, live video and ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... problems ranging from gum disease to enamel erosion, and those dental problems can ... Department of Public Health, many pregnant women are failing to get the dental ...
(Date:1/17/2017)... ... January 17, 2017 , ... Anesthesia Progress – Everyone ... choose the best drug option for each patient. Dentists have several general anesthesia alternatives ... outcomes. , Researchers from the Tokyo Dental College in Tokyo, Japan wanted to find ...
(Date:1/17/2017)... ... January 17, 2017 , ... For breast cancer clinicians and researchers ... those who desire a more intimate review and analysis of its highlights, a novel ... Bedside—is being offered by Imedex on February 4, 2017 in Chicago. Chaired by Kathy ...
Breaking Medicine News(10 mins):